AAN 2023 | Using AI to predict epilepsy surgery outcomes
Daniel Goldenholz, MD, PhD, Beth Israel Deaconess Medical Center, Boston, MA, discusses the use of artificial intelligence (AI) to predict epilepsy surgery outcomes. It has been known for decades that surgery is vastly superior to pharmacological therapy in terms of seizure-free outcomes; however, only a small portion of eligible patients gets surgery. One of the main challenges is predicting long-term seizure freedom and identifying the patients that won’t benefit from surgery. Using AI as an extra tool to make informed decisions regarding surgical interventions may hold hope for seizure freedom in many patients. This interview took place at the American Academy of Neurology Annual Meeting 2023 in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Dr. Goldenholz has funding from NIH, and BIDMC for research.
Dr. Goldenholz is on advisory boards for Magic Leap, Epilepsy AI and Eyzs.
Dr. Goldenholz has been given renumeration to speak at AAN, ACNS, and AI in Epilepsy and Neurology.
Dr. Goldenholz has consulted for Neuro Event Labs.
